Albert David enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
441————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
225225243260168
28.528.510.02.15.3
244————
−197−197−233−258−163
₹427.04————
420420403385317
6.8%6.8%2.5%0.5%1.7%
0.12×————
0.67×————
9.11×————
14.26×————
Reference items — trailing FY values
364334346362342
26.85.53.046.944.3
17.1−4.3−3.940.135.8
—−7.7−28.445.510.5
−7.7−7.7−43.334.65.3
—−9.1−45.434.65.2
—0.014.910.95.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ALBERTDAVD₹772.00

Albert David Limited

· Pharma & Health
₹ CrorePeersVALIANTLABHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹441 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————440.6
- Cash, Equiv & ST Investments168.2259.7242.6225.4225.4
+ Total Debt5.32.110.028.528.5
Enterprise Value————243.7
Net Debt (memo)-162.9-257.6-232.6-196.9-196.9
EV per Share————427.04
Total Capital316.9385.1402.5420.0420.0
Total Debt/Total Capital1.680.552.506.786.78
Total Debt/EV————0.12
EV/Sales————0.67
EV/EBITDA————9.11
EV/EBIT————14.26
Reference Items — Trailing FY Values
Sales341.6362.5345.8333.6364.4
EBITDA44.346.93.05.526.8
EBIT35.840.1-3.9-4.317.1
Operating Cash Flow10.545.5-28.4-7.7—
Free Cash Flow5.334.6-43.3-7.7-7.7
FCFF (free cash flow to the firm)5.234.6-45.4-9.1—
Capital Expenditure5.210.914.90.0—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.